Gsa Capital Partners LLP Acumen Pharmaceuticals, Inc. Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
A detailed history of Gsa Capital Partners LLP transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 32,103 shares of ABOS stock, worth $64,848. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,103Holding current value
$64,848% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding ABOS
# of Institutions
70Shares Held
38.8MCall Options Held
31.5KPut Options Held
0-
Ra Capital Management, L.P. Boston, MA14.9MShares$30.2 Million0.38% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$6.9 Million1.28% of portfolio
-
Franklin Resources Inc San Mateo, CA3.08MShares$6.22 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$4.36 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.95MShares$3.94 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $81.8M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...